TP53 and familial pancreatic carcinoma: Firstly, Sugimoto et al. revealed that depletion of RUNX2 improves GEM sensitivity of p53-negative pancreatic cancer AsPC-1 cells through the stimulation of TAp63-dependent cell death pathway [21].